Pharmafile Logo
Pharmafocus logo
Advanced Search

PL Bioscience

Showing 3 posts of 3 posts found.

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026
Manufacturing and Production PL Bioscience

PL BioScience has announced the appointment of Maik Jornitz to its board of directors, effective immediately. Jornitz brings technical expertise, …

Appointment

PL BioScience appoints Oliver Dick as chief technology officer

June 12, 2025
Clinical trials supplies & documentation logistics, Manufacturing and Production, Research and Development Corporate, Devices, Human Platelet Lysate, PL Bioscience, animal-free cell culture, life sciences

PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell …

Appointment

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

May 23, 2025
Research and Development Animal-Free, Artificial Human Platelets, Corporate, DewCell, Haematology, Human Platelet Lysate, Letter of Intent, Oncology, PL Bioscience

PL BioScience and DewCell Biotherapeutics have signed a Letter of Intent (LOI) for the development and supply of artificial human …

News
Press release
The Gateway to Local Adoption Series

Latest content

Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison

October 23, 2026

Bramacare opens supported-living facility for eating disorder recovery

October 23, 2026

Aiforia deal to expand access to pathology AI

October 22, 2026

SMC accepts atogepant for acute migraine treatment in Scotland

October 22, 2026

New CCO Ogburn joins Cori Clinical

October 21, 2026